15th INTERNATIONAL CONGRESS OF PARKINSON'S
15th INTERNATIONAL CONGRESS OF PARKINSON'S
15th INTERNATIONAL CONGRESS OF PARKINSON'S
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Daily Schedule<br />
Sunday Sunday and Monday<br />
36<br />
Sunday, June 5 2011<br />
1107 Therapeutic Plenary Session III continued<br />
3. Interpret advantages and caveats of MR imaging<br />
techniques in the procedural and postoperative<br />
assessment of Deep Brain Stimulation<br />
Recommended Audience: Clinical Academicians; Practitioners;<br />
Non-Physician Health Professionals; Students/Residents/Trainees<br />
Supported by an unrestricted educational grant from Medtronic, Inc.<br />
1108 Therapeutic Plenary Session IV<br />
Hot topics in experimental therapeutics in<br />
Parkinson’s disease<br />
16:30 – 18:30<br />
Location: South Building, Level 800, Hall FG<br />
Chairs: Olle Lindvall<br />
Lund, Sweden<br />
C. Warren Olanow<br />
New York, NY, USA<br />
16:30 Neuropharmacological treatment: Present and future<br />
Heinz Reichmann<br />
Dresden, Germany<br />
17:10 Options for modifying the disease process<br />
Anthony Schapira<br />
London, United Kingdom<br />
17:50 Gene and cell therapy: How far are we from a clinical<br />
treatment and which are the critical issues for future<br />
trials?<br />
Roger Barker<br />
Cambridge, United Kingdom<br />
At the conclusion of this session, participants<br />
should be better able to:<br />
1. Discuss novel pharmacological approaches to treating<br />
Parkinson’s disease<br />
2. Review potential mechanisms of modifying<br />
Parkinson’s disease by interfering with the disease<br />
process<br />
3. Discuss the possibilities of using cell and gene therapy<br />
to treat Parkinson’s disease<br />
Recommended Audience: Basic Scientists; Clinical<br />
Academicians; Practitioners; Non-Physician Health Professionals;<br />
Students/Residents/Trainees<br />
Supported by an unrestricted educational grant from Elan.<br />
Opening Ceremony<br />
19:00 – 19:30<br />
Location: South Building, Level 800, Hall FG<br />
Welcome Reception<br />
19:30 – 21:00<br />
Location: South Building, Level 800, Hall D<br />
Monday, June 6, 2011<br />
2103 Plenary Session V<br />
The mysterious motor function of the basal<br />
ganglia: Reconsidering David Marsden’s Robert<br />
Wartenberg Lecture of 1981<br />
8:00 – 10:00<br />
Location: South Building, Level 800, Hall FG<br />
Chairs: Mark Hallett<br />
Bethesda, MD, USA<br />
Anthony Lang<br />
Toronto, ON, Canada<br />
8:00 The mysterious motor function of the basal ganglia<br />
revisited<br />
Jose Obeso<br />
Pamplona, Spain<br />
8:40 The influence of David Marsden’s Wartenberg lecture<br />
on models of basal ganglia function<br />
Peter Redgrave<br />
Sheffield, United Kingdom<br />
9:20 The role of oscillations in normal and abnormal basal<br />
ganglia function<br />
Peter Brown<br />
Oxford, United Kingdom<br />
At the conclusion of this session, participants should be<br />
better able to:<br />
1. Document the evolution of views of basal ganglia<br />
function from 1981-2011<br />
2. Recognize basal ganglia roles in motor, sensory<br />
associative and limbic functions<br />
3. Understand basal ganglia physiology in normal and<br />
pathological states<br />
Recommended Audience: Basic Scientists; Clinical<br />
Academicians; Practitioners; Non-Physician Health Professionals;<br />
Students/Residents/Trainees<br />
2104 Plenary Session VI<br />
Cognitive decline in movement disorders<br />
10:30 – 12:30<br />
Location: South Building, Level 800, Hall FG<br />
Chairs: David Burn<br />
Newcastle upon Tyne, United Kingdom<br />
Dennis Dickson<br />
Jacksonville, FL, USA<br />
10:30 Anatomical substrate of cognitive decline in<br />
parkinsonian disorders<br />
Kenji Kosaka<br />
Yokohama, Japan<br />
11:10 The clinical spectrum of dementia in parkinsonian<br />
disorders<br />
Bruno Dubois<br />
Paris, France
Change language